Company & Sponsor Intelligence

University of Wisconsin, Madison

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials17

Recruiting3

Completed10

Countries1

Therapeutic footprint

adhdalzheimersanxietyautismdepressionepilepsyother_psychiatryparkinsons

Indexed studies

NCT05592366Dementia Care Partner Hospital Assessment Tool
alzheimers · United StatesNA

NCT00486044Evaluating Simvastatin's Potential Role in Therapy
alzheimers · United StatesPHASE2

NCT06616948In-home Cycling for Individuals With PD: Effectiveness
parkinsons · United StatesNA

NCT05689541Development of a Parent-mediated Mobile App Intervention for Parents of Children With Autism Spectrum Disorder Participating in an Adapted Horseback Riding Program
autism · United StatesNA

NCT03071120Parent-Mediated Intervention for Families With Children With Autism and Feeding Challenges
autism · United StatesNA

NCT07520955Lily's Grace Temporal Interference
epilepsy · United StatesNA

NCT0718207110-Week Physical Activity Program for Mothers of Children With Developmental Disabilities
autism · United StatesNA

NCT05884307Trans Care: An Online Intervention to Reduce Symptoms of Gender Dysphoria
other_psychiatry · United StatesNA

NCT06377241ScentAware and OCT in MCI vs HC
alzheimers · United StatesTERMINATED

NCT03523663System for Determining Ideal Drug Doses for ADHD - Stages 1 and 2
adhd · United StatesTERMINATED

NCT00204815Bone Mineral Density in Pediatric Epilepsy
epilepsy · United StatesCOMPLETED

NCT00585572Wisconsin Brain Donor Program
alzheimers · United StatesENROLLING_BY_INVITATION

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →